Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Maryann Degroote to Humans

This is a "connection" page, showing publications Maryann Degroote has written about Humans.

 
Connection Strength
 
 
 
0.032
 
  1. Reisfeld B, Metzler CP, Lyons MA, Mayeno AN, Brooks EJ, Degroote MA. A physiologically based pharmacokinetic model for capreomycin. Antimicrob Agents Chemother. 2012 Feb; 56(2):926-34.
    View in: PubMed
    Score: 0.011
  2. Davidson RM, DeGroote MA, Marola JL, Buss S, Jones V, McNeil MR, Freifeld AG, Elaine Epperson L, Hasan NA, Jackson M, Iwen PC, Salfinger M, Strong M. Mycobacterium talmoniae sp. nov., a slowly growing mycobacterium isolated from human respiratory samples. Int J Syst Evol Microbiol. 2017 Aug; 67(8):2640-2645.
    View in: PubMed
    Score: 0.004
  3. Mahapatra S, Hess AM, Johnson JL, Eisenach KD, DeGroote MA, Gitta P, Joloba ML, Kaplan G, Walzl G, Boom WH, Belisle JT. A metabolic biosignature of early response to anti-tuberculosis treatment. BMC Infect Dis. 2014 Jan 31; 14:53.
    View in: PubMed
    Score: 0.003
  4. Dooley KE, Mitnick C, Degroote MA, Obuku E, Hamilton CD, Makhene M, Shah S, Brust JC, Durakovic N, Nuermberger E. Reply to Seddon, Schaaf, and Hesseling. Clin Infect Dis. 2013 Jan; 56(1):168-9.
    View in: PubMed
    Score: 0.003
  5. Franzblau SG, DeGroote MA, Cho SH, Andries K, Nuermberger E, Orme IM, Mdluli K, Angulo-Barturen I, Dick T, Dartois V, Lenaerts AJ. Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis. Tuberculosis (Edinb). 2012 Nov; 92(6):453-88.
    View in: PubMed
    Score: 0.003
  6. Renna M, Schaffner C, Brown K, Shang S, Tamayo MH, Hegyi K, Grimsey NJ, Cusens D, Coulter S, Cooper J, Bowden AR, Newton SM, Kampmann B, Helm J, Jones A, Haworth CS, Basaraba RJ, DeGroote MA, Ordway DJ, Rubinsztein DC, Floto RA. Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest. 2011 Sep; 121(9):3554-63.
    View in: PubMed
    Score: 0.003
  7. Lenaerts AJ, Degroote MA, Orme IM. Preclinical testing of new drugs for tuberculosis: current challenges. Trends Microbiol. 2008 Feb; 16(2):48-54.
    View in: PubMed
    Score: 0.002
  8. Kim JS, Tanaka N, Newell JD, Degroote MA, Fulton K, Huitt G, Lynch DA. Nontuberculous mycobacterial infection: CT scan findings, genotype, and treatment responsiveness. Chest. 2005 Dec; 128(6):3863-9.
    View in: PubMed
    Score: 0.002
  9. Gardner EM, Burman WJ, DeGroote MA, Hildred G, Pace NR. Conventional and molecular epidemiology of macrolide resistance among new Mycobacterium avium complex isolates recovered from HIV-infected patients. Clin Infect Dis. 2005 Oct 01; 41(7):1041-4.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)